Omnibus Incentive Plan (Tables)
|
9 Months Ended |
May 29, 2021 |
| Share-based Payment Arrangement [Abstract] |
|
| Stock option activity |
The following table summarizes stock option activity for the thirty-nine weeks ended May 29, 2021: | | | | | | | | | | | | | | | | | | | | | | | Shares underlying options | | Weighted average exercise price | | Weighted average remaining contractual life (years) | | Outstanding as of August 29, 2020 | | 2,615,899 | | | $ | 14.33 | | | | | Granted | | 289,555 | | | 20.47 | | | | | Exercised | | (58,308) | | | 12.00 | | | | | Forfeited | | (53,983) | | | 22.33 | | | | | Outstanding as of May 29, 2021 | | 2,793,163 | | | $ | 14.86 | | | 6.85 | | | | | | | | | Vested and expected to vest as of May 29, 2021 | | 2,793,163 | | | $ | 14.86 | | | 6.85 | | | | | | | | | Exercisable as of May 29, 2021 | | 2,215,040 | | | $ | 13.25 | | | 6.37 |
|
| Restricted stock activity |
The following table summarizes restricted stock unit activity for the thirty-nine weeks ended May 29, 2021: | | | | | | | | | | | | | | | | | Restricted Stock Units | | Weighted average grant-date fair value | | Non-vested as of August 29, 2020 | | 208,023 | | | $ | 22.82 | | | Granted | | 423,387 | | | 24.84 | | | Vested | | (79,381) | | | 25.08 | | | Forfeited | | (48,735) | | | 21.33 | | | Non-vested as of May 29, 2021 | | 503,294 | | | $ | 24.31 | |
|
| Performance stock unit activity |
The following table summarizes performance stock unit activity for the thirty-nine weeks ended May 29, 2021: | | | | | | | | | | | | | | | | | Performance stock units | | Weighted average grant-date fair value | | Non-vested as of August 29, 2020 | | 295,256 | | | $ | 17.93 | | | Granted | | 116,309 | | | 23.59 | | | Vested | | — | | | — | | | Forfeited | | (30,688) | | | 22.28 | | | Non-vested as of May 29, 2021 | | 380,877 | | | $ | 19.31 | |
|
| Stock appreciation right activity |
The following table summarizes SARs activity for the thirty-nine weeks ended May 29, 2021: | | | | | | | | | | | | | | | | | | | | | | | Shares underlying SARs | | Weighted average exercise price | | Weighted average remaining contractual life (years) | | Outstanding as of August 29, 2020 | | 150,000 | | | $ | 24.20 | | | | | Granted | | — | | | — | | | | | Exercised | | — | | | — | | | | | Forfeited | | — | | | — | | | | | Outstanding as of May 29, 2021 | | 150,000 | | | $ | 24.20 | | | 8.43 | | | | | | | | | Vested and expected to vest as of May 29, 2021 | | 150,000 | | | $ | 24.20 | | | 8.43 | | | | | | | | | Exercisable as of May 29, 2021 | | — | | | $ | — | | | 0.00 |
|